FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2518442922> ?p ?o ?g. }

• W2518442922 endingPage "972" @default.
• W2518442922 startingPage "967" @default.
• W2518442922 abstract "In Canada, cardiovascular diseases (CVD) are the leading cause of mortality. In 1998, CVD were responsible for 39,447 deaths among Canadian women (almost 38% of all deaths in women), which is greater than the number of deaths for women due to all cancers combined. The proportion of deaths due to CVD in women increases significantly after menopause and continues to increase with advancing age. It remains unclear, however, whether this increase in incidence of CVD in middle-aged and elderly women is caused by lower estrogen levels or is an overall manifestation of advancing age. The use of hormone replacement therapy (HRT), especially estrogen, has been advocated as a means to reduce the risk of CVD. Menopause is associated with adverse effects on blood lipids including an increase in total cholesterol, LDL cholesterol, and triglycerides, and a decrease in HDL cholesterol. Reduced estrogen levels after menopause can also lead to adverse changes in blood pressure, obesity, body fat distribution, blood clotting factors, glucose metabolism and diabetes, all of which increase the risk of coronary heart disease. Laboratory studies have found evidence for both beneficial and adverse effects of estrogen. Oral estrogen has been shown to lower LDL cholesterol, lipoprotein (a), and increase HDL cholesterol. There is accumulating evidence that estrogen improves endothelial function, thus enhancing vasodilatation. In addition, estrogen replacement is associated with reduced blood levels of fibrinogen and plasminogen activator inhibitor-1, and may thus have anti-thrombotic and pro-fibrinolytic effects. However, other effects may be pro-inflammatory (increased C-reactive protein) and pro-coagulant and therefore detrimental to the overall cardiovascular risk profile. As estrogen is usually prescribed with progestin in those women with a uterus in order to protect against endometrial cancer, some of the beneficial cardiovascular effects may be attenuated by the addition of progestin (such as a lesser effect on HDL cholesterol). Other routes of administration of estrogen may have less favourable effects on plasma lipoproteins, but may be beneficial in other ways. Selective estrogen receptor modulators (SERMs) are also being studied because these may result in direct cardiovascular effects. The evidence for a protective effect of estrogen on coronary heart disease is based on over 30 observational epidemiologic studies conducted over the last two decades. These studies have shown a 40% reduction in the risk of coronary heart disease for current users of estrogen or estrogen and progestin compared to women who have never used these hormones. Recent updates have confirmed this conclusion, even with lower doses of estrogen, and have also found no effect of HRT on stroke. However, these types of studies are hampered by an inability to control completely for confounding factors, including the fact that women who are compliant with HRT" @default.
• W2518442922 created "2016-09-16" @default.
• W2518442922 creator A5022771172 @default.
• W2518442922 creator A5074714578 @default.
• W2518442922 date "2001-10-01" @default.
• W2518442922 modified "2023-09-27" @default.
• W2518442922 title "Hormone Replacement Therapy and Cardiovascular Disease" @default.
• W2518442922 cites W1562190372 @default.
• W2518442922 cites W1963521889 @default.
• W2518442922 cites W1966701899 @default.
• W2518442922 cites W1970028985 @default.
• W2518442922 cites W1987144846 @default.
• W2518442922 cites W1988567074 @default.
• W2518442922 cites W1988882351 @default.
• W2518442922 cites W1997512708 @default.
• W2518442922 cites W1998958700 @default.
• W2518442922 cites W2003196466 @default.
• W2518442922 cites W2007841512 @default.
• W2518442922 cites W2024947181 @default.
• W2518442922 cites W2059022881 @default.
• W2518442922 cites W2068850103 @default.
• W2518442922 cites W2073031659 @default.
• W2518442922 cites W2078878902 @default.
• W2518442922 cites W2082192422 @default.
• W2518442922 cites W2104926369 @default.
• W2518442922 cites W2107766028 @default.
• W2518442922 cites W2112061209 @default.
• W2518442922 cites W2112233548 @default.
• W2518442922 cites W2113264115 @default.
• W2518442922 cites W2130451642 @default.
• W2518442922 cites W2135568455 @default.
• W2518442922 cites W2140385110 @default.
• W2518442922 cites W2144795879 @default.
• W2518442922 cites W2290627980 @default.
• W2518442922 cites W2332056249 @default.
• W2518442922 cites W2332987513 @default.
• W2518442922 cites W2333702587 @default.
• W2518442922 cites W2341922045 @default.
• W2518442922 cites W2615633554 @default.
• W2518442922 cites W2972867833 @default.
• W2518442922 cites W4254959959 @default.
• W2518442922 cites W4296976561 @default.
• W2518442922 doi "https://doi.org/10.1016/s0849-5831(16)30866-7" @default.
• W2518442922 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12196851" @default.
• W2518442922 hasPublicationYear "2001" @default.
• W2518442922 type Work @default.
• W2518442922 sameAs 2518442922 @default.
• W2518442922 citedByCount "3" @default.
• W2518442922 countsByYear W25184429222017 @default.
• W2518442922 countsByYear W25184429222022 @default.
• W2518442922 crossrefType "journal-article" @default.
• W2518442922 hasAuthorship W2518442922A5022771172 @default.
• W2518442922 hasAuthorship W2518442922A5074714578 @default.
• W2518442922 hasConcept C121608353 @default.
• W2518442922 hasConcept C126322002 @default.
• W2518442922 hasConcept C177713679 @default.
• W2518442922 hasConcept C2779134260 @default.
• W2518442922 hasConcept C2779279991 @default.
• W2518442922 hasConcept C2780159708 @default.
• W2518442922 hasConcept C2780275930 @default.
• W2518442922 hasConcept C3020211606 @default.
• W2518442922 hasConcept C530470458 @default.
• W2518442922 hasConcept C71315377 @default.
• W2518442922 hasConcept C71924100 @default.
• W2518442922 hasConceptScore W2518442922C121608353 @default.
• W2518442922 hasConceptScore W2518442922C126322002 @default.
• W2518442922 hasConceptScore W2518442922C177713679 @default.
• W2518442922 hasConceptScore W2518442922C2779134260 @default.
• W2518442922 hasConceptScore W2518442922C2779279991 @default.
• W2518442922 hasConceptScore W2518442922C2780159708 @default.
• W2518442922 hasConceptScore W2518442922C2780275930 @default.
• W2518442922 hasConceptScore W2518442922C3020211606 @default.
• W2518442922 hasConceptScore W2518442922C530470458 @default.
• W2518442922 hasConceptScore W2518442922C71315377 @default.
• W2518442922 hasConceptScore W2518442922C71924100 @default.
• W2518442922 hasIssue "10" @default.
• W2518442922 hasLocation W25184429221 @default.
• W2518442922 hasOpenAccess W2518442922 @default.
• W2518442922 hasPrimaryLocation W25184429221 @default.
• W2518442922 hasRelatedWork W1977664992 @default.
• W2518442922 hasRelatedWork W2071866325 @default.
• W2518442922 hasRelatedWork W2126878050 @default.
• W2518442922 hasRelatedWork W2170260649 @default.
• W2518442922 hasRelatedWork W2315905420 @default.
• W2518442922 hasRelatedWork W2326002320 @default.
• W2518442922 hasRelatedWork W2402254432 @default.
• W2518442922 hasRelatedWork W2461381607 @default.
• W2518442922 hasRelatedWork W3104983592 @default.
• W2518442922 hasRelatedWork W4240821743 @default.
• W2518442922 hasVolume "23" @default.
• W2518442922 isParatext "false" @default.
• W2518442922 isRetracted "false" @default.
• W2518442922 magId "2518442922" @default.
• W2518442922 workType "article" @default.